Vanguard Group Inc Passage Bio, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Passage Bio, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,071,538 shares of PASG stock, worth $2.07 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,071,538
Previous 2,018,882
2.61%
Holding current value
$2.07 Million
Previous $2.04 Million
37.13%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding PASG
# of Institutions
52Shares Held
33MCall Options Held
20.3KPut Options Held
500-
Orbimed Advisors LLC San Diego, CA10.1MShares$10.1 Million0.31% of portfolio
-
Versant Venture Management, LLC San Francisco, CA4.96MShares$4.96 Million9.33% of portfolio
-
Vestal Point Capital, LP New York, NY4.5MShares$4.5 Million0.5% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY2.5MShares$2.5 Million2.96% of portfolio
-
Tang Capital Management LLC San Diego, CA1.5MShares$1.5 Million0.25% of portfolio
About Passage BIO, Inc.
- Ticker PASG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,463,200
- Market Cap $54.5M
- Description
- Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...